PREGNANCY HEMODYNAMICS

Thomas L. Archer, MD, MBA
Former Clinical Professor of Anesthesiology
Former Director of Obstetric Anesthesia
University of California San Diego School of Medicine

EXPLORING HOW MATERNAL BODY POSITION AND OBSTRUCTION OF UTERINE VENOUS RETURN (OUVR) MAY AFFECT FETAL AND MATERNAL OXYGENATION AND LIFELONG HEALTH OUTCOMES

Illustration of the pregnant uterus compressing the inferior vena cava, shown in side and cross-sectional views
The images above show “aortocaval compression,” which is when the pregnant uterus compresses both the inferior vena cava and the abdominal aorta against the lower spine. The commonest maternal position in which this blockage occurs is the “supine” position, that is, when the mother-to-be is lying flat on her back, but this type of obstruction can occur in other maternal positions as well. This website presents theories about possible bad outcomes for both the fetus and the mother when the uterus obstructs the inferior vena cava and-- in the process-- obstructs the veins and “venous return” of the uterus itself. To describe this possibly harmful blockage of the uterine circulation from its venous side, this website uses the term “obstruction of uterine venous return,” or “OUVR.”

I have built this website to draw attention to an idea which I have been developing with my colleagues since 2011. The idea may be important for improving the lifelong health of mothers and babies. Many obstetricians, maternal-fetal medicine specialists and medical scientists have made favorable comments about the idea, but it has not received as much direct research attention as I believe it deserves. That is why I am reaching out to you with this website—to encourage education, discussion and research about what is actually a very simple idea which has largely been ignored.

The idea is that unfavorable maternal body positions during the second half of pregnancy might chronically and intermittently deprive the fetus, placenta and uterine muscle (myometrium) of oxygen, and that this repetitive oxygen deprivation might contribute to the causation of preeclampsia, fetal growth restriction, preterm birth, dysfunctional labor, cesarean delivery and postpartum hemorrhage. This idea may sound “far out” or “crazy,” but it is actually based on well-understood maternal anatomy and physiology and on well-known clinical scenarios.

What makes this idea especially ripe for investigation now is that we may now have the understanding and technology needed to detect unfavorable maternal body positions in real time and to warn the pregnant woman to change her body position in order to protect her developing baby. This warning might come from inconspicuous wearable devices which continuously monitor her cardiovascular system, and which would not only warn a mother when her body position appeared to be bad for the fetus, but would also reassure her when her new body position had improved her delivery of oxygen to her baby.

Now that I have made these “wild” claims and presented an equally “fanciful” solution, I must immediately tell you that these ideas constitute an (almost) totally unproven theory, and that the desired wearable devices are awaiting development! However, if this theory is true-- or even partly true—further research might lead to improvements in the lifelong health of millions of people and prevent much human suffering. Furthermore, this contribution to better human health would have been accomplished without the development of new drugs, and it would have been accomplished by simply giving the developing fetus all the oxygen it needs to develop to its full potential.

With this rationale, medical investigators should evaluate whether positional chronic oxygen deprivation of the fetus, placenta and myometrium can cause unfavorable pregnancy outcomes, and if it can, then “positional fetal oxygenation management” might become a routine part of prenatal care.

I should also clarify here on my homepage that I am a retired anesthesiologist with experience working with pregnant patients and their caregivers, but I am not an obstetrician-gynecologist or maternal fetal medicine specialist.

If the ideas presented here interest you, please feel free to start a discussion in the Contact and comment section. I hope to hear from non-medically trained people, health care professionals and scientists. In your questions or comments please do not reveal any personal medical information.

Thank you for visiting my website.

DISCLAIMER:

The only purpose of this site is to promote education, discussion and research. This website does not offer medical advice and many of the ideas and theories presented in this website are completely unproven and speculative. If you have individual medical concerns, please consult your own personal healthcare professionals. By training and past medical practice, I am an anesthesiologist and not an obstetrician-gynecologist or maternal fetal medicine specialist.

Selected articles

Could your body position affect oxygen delivery to your unborn baby?

Published here October 3, 2026

Read the article

Therapeutic trials of maternal position therapy are needed to clarify the causes of abnormal maternal hemodynamic profiles and reduced umbilical vein flow in fetal growth restriction

Journal of Perinatal Medicine — Published online January 14, 2026

Download PDF

Let’s use diverse technologies to assess maternal hemodynamics– both before and during labor and to both predict and prevent bad outcomes!

Journal of Perinatal Medicine — Published online January 9, 2026

Download PDF

Cardiac output-guided maternal positioning may improve the usefulness of maternal cardiovascular profiles

American Journal of Obstetrics and Gynecology — Letter to the Editors

Download PDF

Cardiac output-guided maternal positioning in pregnancy-- can it improve outcomes?

Best Practice & Research Clinical Obstetrics & Gynaecology — 2025, volume 100, article 102596

Download PDF

Transthoracic echocardiography and electrical cardiometry elucidate the hemodynamics of autotransfusion during labor under epidural analgesia

International Journal of Obstetric Anesthesia — 2017

Download PDF

Maximisation of maternal cardiac output during labour might help to prevent not only foetal hypoxaemia but also myometrial ischaemia, dysfunctional labour, uterine atony and postpartum endometritis

Anaesthesia and Intensive Care — July 2011

Download PDF

Cardiac output measurement, by means of electrical velocimetry, may be able to determine optimum maternal position during gestation, labour and caesarean delivery, by preventing vena caval compression and maximising cardiac output and placental perfusion pressure

Anaesthesia and Intensive Care — 2011, 39, 308–311

Download PDF

Return to home page

Selected presentations
Fetal growth restriction

Does a lack of oxygen cause both fetal growth restriction and preeclampsia?

Fetal growth restriction can be accompanied by preeclampsia, or it can occur without preeclampsia. Similarly, preeclampsia can be associated with fetal growth restriction, but it can also occur in the presence of a normally grown fetus. Both fetal growth restriction and preeclampsia are syndromes, rather than discrete disease states, and both syndromes probably have multiple pathways of causation. Nevertheless, one of the main theories presented in this website (and in my book) is that both preeclampsia and fetal growth restriction are frequently caused—at least in part-- by a lack of oxygen in either the chorionic villi, the fetus, or in both locations.

I propose the model that preeclampsia occurs when the chorionic villi are deprived of oxygen, whereas fetal growth restriction occurs when the fetus is deprived of oxygen, and I also propose that OUVR contributes to this oxygen deprivation by two separate mechanisms: decreased IVS flow and increased IVS pressure. I further propose that poor spiral artery remodeling— the putative cause of preeclampsia— only decreases IVS flow, without increasing IVS pressure. This possible distinction between the mechanisms of OUVR and those of poor spiral artery remodeling for decreasing fetal and placental oxygenation is shown schematically in Figure 19.

Obstruction of uterine venous return may decrease both uteroplacental and fetoplacental perfusion

So far, we have only looked at the effects of OUVR on the flow of maternal blood through the IVS, the uteroplacental perfusion. What about the fetoplacental perfusion-- the perfusion of the chorionic villi by the fetal cardiovascular system, including the fetal vessels within the CV? The transfer of oxygen from the mother to the fetus depends on the viability of both the uteroplacental and fetoplacental circulations, and OUVR may impair the fetoplacental circulation by increasing the hydrostatic pressure within the IVS and thereby compressing the chorionic villi and the fetal vessels within them. There is evidence that increased IVS pressure does, in fact, decrease fetoplacental perfusion, and this effect on the fetoplacental circulation has been termed “sluice flow.” The Figures below illustrate this entire theory that OUVR may contribute to the causation of FGR by both decreasing IVS flow (uteroplacental perfusion) and by increasing IVS pressure, which decreases fetoplacental perfusion.

Figure 14The perfect intervillous space—high flow, low pressure and no “hits”

Figure 14: no obstruction of uterine venous return, low-resistance spiral artery, normal oxygen partial pressure, normal intervillous space pressure and normal uteroplacental perfusion
This Figure shows a normal intervillous space, without OUVR and without maternal blood inflow restriction due to high resistance spiral arteries. Both OUVR and high resistance spiral arteries increase resistance to perfusion of the IVS, the first from the venous side of the space and the second from the arterial side, and both of these conditions—neither of which is present in this Figure—can be considered as threats to IVS perfusion. I am therefore calling each of these threats potential “hits” to fetal and maternal health—but neither of these “hits” is present in this Figure.
Abbreviations: IVSP intervillous space pressure, OUVR obstruction of uterine venous return, pO2 partial pressure of oxygen (oxygen tension)

Figure 15The perfect intervillous space: abundant uteroplacental and fetoplacental perfusion due to normally remodeled spiral arteries, no OUVR and normal intervillous space pressure

Figure 15: unobstructed IVC, low-resistance spiral artery, normal oxygen partial pressure and intervillous space pressure, normal uteroplacental perfusion, non-compressed chorionic villi, normal fetoplacental perfusion and a well-oxygenated fetus
This Figure shows the chorionic villi within the hemodynamically favorable IVS as shown in Figure 14. In this Figure, the CV are simply shown as a compressible rectangle or “box” of tissue with fetal blood vessels inside, and the benign hemodynamic situation shown allows both 1) abundant maternal blood flow through the IVS (uteroplacental perfusion), and 2) abundant fetoplacental perfusion of the CV, due to the presence of normally remodeled spiral arteries, the lack of OUVR and the normal intervillous space pressure. So far, so good for oxygenation of both the CV and the fetus!
Abbreviations: CV chorionic villi, IVC inferior vena cava, IVSP intervillous space pressure, pO2 partial pressure of oxygen (oxygen tension), UmbArt umbilical artery, UmbVein umbilical vein

Figure 16One “hit”: Obstruction of uterine venous return decreases uteroplacental perfusion and increases intervillous space pressure

Figure 16: obstruction of uterine venous return, high intervillous space pressure, low oxygen partial pressure and decreased uteroplacental perfusion despite a low-resistance spiral artery
This Figure shows how OUVR not only decreases IVS perfusion but also increases IVS pressure. In this Figure, OUVR is termed as the “second hit,” but fortunately there is no “first hit” since the spiral arteries have been favorably remodeled and have low resistance.
Abbreviations: IVSP intervillous space pressure, OUVR obstruction of uterine venous return, pO2 partial pressure of oxygen (oxygen tension)

Figure 17One “hit”: Obstruction of uterine venous return decreases both uteroplacental and fetoplacental perfusion and “stresses” both the CV and the fetus.

Figure 17: obstruction of uterine venous return, high intervillous space pressure, low oxygen partial pressure, reduced uteroplacental perfusion, compressed chorionic villi, reduced fetoplacental perfusion, anti-angiogenic factor and a hypoxic fetus
This Figure shows how OUVR increases IVS pressure and thereby compresses the CV and the fetal vessels within them. In this situation, both uteroplacental perfusion and fetoplacental perfusion are impaired and—even with only one “hit” to the system—both the fetus and chorionic villi are showing signs of hypoxic stress. In this Figure, the stress to the CV is shown to cause the release of small numbers of anti-angiogenic factors into the maternal circulation, suggesting that clinical preeclampsia may develop in the future. But this entire Figure is speculation!
Abbreviations: CV chorionic villi, IVSP intervillous space pressure, OUVR obstruction of uterine venous return, pO2 partial pressure of oxygen (oxygen tension), UmbArt umbilical artery, UmbVein umbilical vein

Figure 18Two “hits” cause disaster: Obstruction of uterine venous return plus high resistance spiral arteries further decrease fetal and CV oxygenation, thereby triggering full-blown preeclampsia.

Figure 18: proposed two-hit model with high spiral artery resistance, obstruction of uterine venous return, high intervillous space pressure, very low oxygen partial pressure, compressed chorionic villi, reduced uteroplacental and fetoplacental perfusion, and a very hypoxic fetus with fetal growth restriction
Figure 18 shows how the “first hit”—the high resistance SAs—can combine with the “second hit”—the OUVR—to make the fetal and CV hypoxia much more serious, and we can imagine that this greatly increased hypoxic stress to the CV causes a massive release of antiangiogenic factors into the maternal blood with the production of full-blown pre-eclampsia. Of course, the reader must remember that this is all just a theory, but one that deserves further investigation!
Abbreviations: CV chorionic villi, FGR fetal growth restriction, IVSP intervillous space pressure, OUVR obstruction of uterine venous return, pO2 partial pressure of oxygen (oxygen tension), UmbArt umbilical artery, UmbVein umbilical vein

Figure 19In addition to decreasing uteroplacental perfusion, OUVR increases intervillous space pressure which decreases fetoplacental perfusion— which constitutes another type of “double hit” to fetal oxygenation!

Figure 19: proposed pathways from defective spiral artery remodeling and obstruction of uterine venous return through decreased uteroplacental perfusion and intervillous oxygen tension to chorionic villus and fetal hypoxia, with an additional pathway from increased intervillous pressure through decreased fetoplacental perfusion to fetal hypoxia
By increasing intervillous space pressure, obstruction of uterine venous return (OUVR) may "preferentially" tend to produce fetal growth restriction, since the increased pressure may directly reduce fetoplacental perfusion and thereby "preferentially" affect fetal oxygenation, as opposed to CV oxygenation. This pressure-related effect of OUVR on fetoplacental circulation is in addition to the fact that OUVR independently decreases uteroplacental circulation and thereby stresses both the CV and the fetus. Again, this Figure is speculation which deserves further research!
Abbreviations: CV chorionic villi, IVS intervillous space, pO2 partial pressure of oxygen
Preeclampsia

Both poorly remodeled spiral arteries and OUVR can independently limit uteroplacental perfusion.

The goal of this Preeclampsia page is to convince you that intervillous space perfusion (uteroplacental perfusion) can be limited either by poorly remodeled spiral arteries or by obstruction of uterine venous return (OUVR). In the latter case, uteroplacental perfusion is limited from the venous side of the circulation, but the effect on intervillous space oxygen tension (pO2) may be the same-- to reduce oxygen delivery to the chorionic villi and the fetus and thereby cause either preeclampsia, fetal growth restriction or both injuries together.

Poorly remodeled spiral arteries and OUVR can work together to make poor oxygenation even worse.

The following six Figures show how reduced oxygen delivery to the intervillous space (IVS) may cause both chorionic villus and fetal hypoxia, and that poorly remodeled spiral arteries and obstruction of uterine venous return might “work together” to make “a bad situation worse” in terms of reducing uteroplacental perfusion and fetoplacental oxygenation. But please keep in mind that this page only shows that poorly remodeled spiral arteries and obstruction of uterine venous return (OUVR) can limit uteroplacental perfusion. As we will see in the Fetal growth restriction section, OUVR may have an additional negative impact on fetal oxygenation because it decreases fetoplacental perfusion-- through the mechanism of increasing intervillous space pressure.

Figure 8Low-pressure intervillous space with abundant perfusion and a well-oxygenated fetus

Figure 8: unobstructed uterine veins, well-remodeled spiral arteries, low intervillous pressure and a well-oxygenated fetus
Figure 8 shows the optimal situation, in which the mother is not anemic, does not live at high altitude and when the intervillous spaces of her placenta are not afflicted with either OUVR or high resistance spiral arteries. In this situation, uteroplacental perfusion, IVS pO2 and oxygenation of both the CV and the fetus are all favorable for good placental function and normal fetal development.
Abbreviations: CV chorionic villi, IVS intervillous space, pO2 partial pressure of oxygen (oxygen tension)

Figure 9Oxygen delivery to the intervillous space can be limited by maternal anemia, by living at high altitude, or by chronic cardiovascular disease which reduces IVS perfusion even in the absence of OUVR or spiral artery impairment.

Figure 9
Figure 9 shows the situation in which there is no OUVR or reduced spiral artery blood flow into the IVS, but where oxygen delivery to the IVS is decreased by some other mechanism, such as maternal anemia, living at high altitude or cardiovascular disease. This Figure is included merely to make the presentation more comprehensive, and these examples of extra-uterine limitations to oxygen delivery will not be considered any further.
Abbreviations: CV chorionic villi, IVS intervillous space, pO2 partial pressure of oxygen (oxygen tension)

Figure 10The most common theory of preeclampsia causation: “poor remodeling” of spiral arteries with decreased uteroplacental perfusion and hypoxia of the chorionic villi and fetus.

Figure 10: defective spiral artery remodeling, reduced intervillous blood flow, hypoxic chorionic villus and fetus, anti-angiogenic factors, preeclampsia and fetal growth restriction, without OUVR
Figure 10 shows one of the most common current theories of the etiology of preeclampsia: restricted IVS perfusion due to high-resistance (or “un-remodeled”) spiral arteries (a “first hit” to oxygenation). In this situation, reduced uteroplacental perfusion with constant oxygen consumption by the CV and the fetus may lead to hypoxia of the CV, leading to preeclampsia, and hypoxia of the fetus, leading to fetal growth restriction. Suggestively, the Figure shows that the “stressed” CV are already releasing some “anti-angiogenic factors” which may lead to the appearance of preeclampsia later.
Abbreviations: CV chorionic villi, IVS intervillous space, OUVR obstruction of uterine venous return, pO2 partial pressure of oxygen (oxygen tension)

Figure 11Obstruction of uterine venous return may be able to reduce uteroplacental perfusion—just like “poorly-remodeled” spiral arteries can!

Figure 11: obstructed inferior vena cava despite well-remodeled spiral arteries, reduced intervillous blood flow, hypoxic chorionic villus and fetus, anti-angiogenic factors, preeclampsia and fetal growth restriction
Figure 11 is a key Figure for the theory presented in this website (and in my book). My argument is that OUVR may be able to produce the same decrease in uteroplacental perfusion as “poorly remodeled” spiral arteries! The important difference between these two causes of reduced IVS perfusion is that a "second hit" of OUVR can be prevented with current technology, whereas the "first hit" of poor spiral artery remodeling cannot be prevented at present.
Abbreviations: IVS intervillous space, OUVR obstruction of uterine venous return, pO2 partial pressure of oxygen (oxygen tension)

Figure 12Proposed “two-hit” mechanism of preeclampsia: defective spiral artery remodeling (the "first hit") combined with OUVR (the preventable "second hit").

Figure 12: proposed first hit from defective spiral artery remodeling and second hit from obstructed IVC, with very reduced intervillous blood flow, severe placental and fetal hypoxia, abundant anti-angiogenic factors, severe preeclampsia and severe fetal growth restriction
Figure 12 is another key Figure for the theories presented here. The key insight is that the combination of poorly remodeled spiral arteries and OUVR may lead to a much worse result than either factor by itself! This “two hit” hypothesis applies to the causation of both preeclampsia and fetal growth restriction: one "hit" is bad, but two may be devastating, and the elimination of OUVR by means of cardiac output-guided maternal positioning might therefore delay the onset or decrease the severity of preeclampsia or fetal growth restriction.
Abbreviations: IVC inferior vena cava, IVS intervillous space, pO2 partial pressure of oxygen (oxygen tension).

Figure 13Both defectively remodeled spiral arteries and obstruction of uterine venous return can decrease uteroplacental perfusion.

Figure 13: diagram linking defective spiral artery remodeling and obstruction of uterine venous return to decreased uteroplacental perfusion, decreased intervillous oxygen tension, chorionic villus hypoxia and preeclampsia, and fetal hypoxia and fetal growth restriction
Defective spiral artery remodeling and obstruction of uterine venous return may both decrease perfusion of the intervillous space-- that is, they may both decrease uteroplacental perfusion, and thereby cause either preeclampsia or fetal growth restriction or both syndromes together.
Abbreviations: CV chorionic villi, IVS intervillous space, pO2 partial pressure of oxygen (oxygen tension)
Known and proposed possible fetal and maternal injuries from OUVR

The supine hypotensive syndrome of pregnancy is a known maternal and fetal complication of late pregnancy when the uterus is large enough to obstruct the inferior vena cava and its own venous return. The Tables below present other proposed possible fetal and maternal complications of unfavorable maternal body position during the second half of pregnancy, but these proposed complications are either speculative or else require further investigation.

Possible fetal injuries from OUVR

  • Chronic oxygen deprivation of fetus causes fetal growth restriction (FGR)
  • Chronic oxygen deprivation of placenta causes preeclampsia with FGR
  • FGR impairs subsequent infant, childhood and adult health
  • Chronic oxygen deprivation of fetus, placenta or myometrium causes preterm birth
  • Acute oxygen deprivation of fetus during labor causes fetal distress and cesarean delivery

Possible maternal injuries from OUVR

  • Chronic oxygen deprivation of placenta causes preeclampsia
  • Oxygen deprivation of myometrium during labor causes dysfunctional labor, requiring oxytocin administration or cesarean delivery
  • Oxygen deprivation of myometrium during labor causes postpartum uterine atony and hemorrhage, or endometritis
  • Cesarean delivery due to preeclampsia, fetal growth restriction, dysfunctional labor or fetal distress
Main idea OUVR

Can we actively protect fetal oxygen delivery during the second half of pregnancy?

Everyone acknowledges the importance of prenatal care, and it is widely accepted that pregnancy involves two “patients”—the mother and the fetus. For the benefit of both, pregnant women are urged to take their vitamins and iron, eat a healthy diet, get exercise and watch their weight. They will also be checked for anemia, high blood pressure, diabetes and urinary tract infections. Even more tests may be performed to detect Down syndrome or other genetic and anatomical abnormalities, and most people are aware of the dangers to the fetus of smoking, alcohol and many other drugs and legal medications.

But in our attempts to optimize fetal growth, development and lifelong health for both baby and mother, could it be that we are overlooking a threat to an absolutely essential “input” for the “production” of a healthy person— namely, an adequate supply of oxygen throughout pregnancy?

Figure 1 below, shows a dangerous maternal hemodynamic situation which occurs commonly during the second half pregnancy.

To understand why the situation shown in Figure 1 is dangerous to the fetus, placenta and myometrium we first have to understand what the unobstructed delivery of oxygen to the fetus and uterus looks like. The fetus gets all of its oxygen from the mother via the placenta, as represented schematically in Figure 2. This Figure shows the ideal situation for fetal, placental and uterine oxygenation during the second half of pregnancy, when the uterus is large enough to obstruct crucial portions of the mother's venous system, but does not do so. Figure 2 shows maternal blood flow in a favorable maternal body position—by which I mean, a body position in which the heavily pregnant uterus is not compressing major maternal pelvic and abdominal veins.

But Figure 3 shows what happens when the mother changes her body position and the pregnant uterus does compress the major veins that carry blood back to the heart from the uterus and the entire lower half of the mother’s body. In this situation (labeled “IVC obstruction”) two bad things happen: 1) within less than a minute the amount of blood returning to the mother’s heart decreases, along with her blood pressure, and 2) the pressure increases within the veins draining the uterus, and this increased venous pressure decreases total blood flow and oxygen delivery to the uterus, placenta and fetus.

The situation shown in Figure 3 was first described in 1953 as the “supine hypotensive syndrome of pregnancy” and consists of maternal distress, pallor, sweating, low blood pressure, nausea, vomiting and an increase in venous pressure in the veins in the groin, when susceptible patients late in pregnancy lie flat on their backs (1). The original description of the syndrome did not emphasize the dangers inherent in the syndrome to the fetus, but rather emphasized the fact that promptly turning the patient onto one side relieved the maternal effects of the syndrome. Thus, the original conception of the syndrome was that of a short-term threat to the mother which could be easily corrected by turning the mother onto her side and thereby relieving the venous obstruction caused by the pregnant uterus.

A corollary of this perspective, however, is that the syndrome forces the mother or her care givers to change her body position, which then restores uterine and placental blood flow and fetal oxygenation—as well as blood flow to the mother’s brain. Hence, the syndrome —although highly unpleasant and dangerous for the mother— can also be seen as a protective response or a “blessing in disguise” which protects both mother and fetus.

But what happens if the mother’s cardiovascular system compensates for the unfavorable situation shown in Figure 3 by increasing the mother’s blood pressure despite the reduction in cardiac output? This situation-- which is thought to occur commonly-- is shown in Figure 4, in which the mother continues to feel well because her blood pressure is maintained, but the blood flow and oxygen delivery to the uterus, placenta and fetus are still impaired. If this situation occurs, the mother’s body position continues to impair oxygen delivery to her developing baby without the mother being aware that something is happening that might harm her baby! This prolonged deprivation of fetal, placental and uterine oxygenation might cause permanent injury.

In this situation, the mother needs a warning that something is going on with her body which might be harmful to her developing baby, and I have suggested that the decrease in cardiac output that accompanies the unfavorable situation shown in Figure 4 could be used as a "warning signal" for the pregnant woman to change her body position. I have coined the term “cardiac output-guided maternal positioning” to describe this process since it would use the tell-tale reduction in maternal cardiac output as an actionable warning signal for the mother to change her body position in real time to restore unobstructed blood flow and oxygen delivery to her reproductive system. This use of positional decreases in maternal cardiac output as a warning signal to protect her baby from a “silent threat” is shown in Figure 5, and this preventive warning system might eventually be embodied in wearable medical devices such as “bracelets,” “rings” or “earrings” which would continuously and non-invasively monitor the pregnant woman’s cardiovascular system and give the mother a discreet warning when her body position appeared to be causing a possible problem for the fetus.

This website (and my 2024 book and previous articles) presents many speculative and completely unproven theories which require much further evaluation. But if even some of these theories are true, the preventive approach to chronic fetal injury which they suggest might improve the lifelong health of both mothers and their children, by ensuring that developing babies will always get all the oxygen they need in order to develop to their full potential.

Figure 1Obstruction of uterine venous return (OUVR) is known to cause the supine hypotensive syndrome of pregnancy, which is a dramatic and sudden event. But can OUVR also cause fetal and maternal injury gradually or sporadically at any time during the second half of pregnancy-- when OUVR is chronic, intermittent and unrecognized? That is the key question posed by this website!

Figure 1: obstruction of uterine venous return and venous engorgement
This Figure shows the gravid uterus compressing the inferior vena cava against the bony “sacral promontory” within the pelvis. This obstruction blocks the return of venous blood to the heart from the entire lower part of the body, including the uterus, and can cause a sudden and severe maternal syndrome called the “supine hypotensive syndrome of pregnancy.” This concept has been understood since at least 1953. What I am adding to the picture is the theory that this same obstruction of the inferior vena cava-- if it is compensated by the maternal cardiovascular system-- may injure both the fetus and the mother in a gradual, intermittent and unrecognized chronic process during the entire second half of pregnancy, when the pregnant uterus is large enough to obstruct its own venous return.

Figure 2No obstruction of uterine venous return (OUVR) means there is no obstruction to ideal fetal and maternal oxygenation

Figure 2
This Figure shows ideal unobstructed maternal blood flow to and from the pregnant uterus and lower body during the second half of gestation. During the second half of pregnancy the uterus is large enough to obstruct major maternal pelvic and abdominal veins, but the uterus is not obstructing the venous system in this picture, because the mother has adopted a favorable body position which prevents major venous obstruction by the mobile uterus. Another key lesson of this Figure is that the cardiac output -- the amount of blood pumped out by the heart per minute-- is the same as the venous return, and that cardiac output is one key determinant of the mother's blood pressure. The other determinant of blood pressure is the systemic vascular resistance, which is set by many compensatory systems within our bodies

Abbreviations: IVC inferior vena cava, O2 oxygen

Figure 3The supine hypotensive syndrome of pregnancy-- a threat to both mother and fetus which is quickly corrected by a rapid change of maternal body position.

Supine hypotensive syndrome of pregnancy: IVC obstruction, decreased cardiac output and blood pressure, and maternal position change
The “supine hypotensive syndrome of pregnancy” represents a threat to the oxygenation of both the mother and the fetus, but it is usually regarded as just a short-term maternal problem which can be corrected by a prompt maternal position change from supine (flat on the back) to a lateral position. But during the syndrome, the fetus is in trouble as well as the mother, and changing the mother’s position may save both the mother and the fetus from injury due to a lack of oxygen. The green-bordered text box in the lower right-hand corner of the Figure shows the restored good condition of the mother and fetus which exists after the beneficial maternal position change has been performed.

Abbreviations: IVC inferior vena cava, L patient’s left side, O2 oxygen, R patient’s right side

Figure 4Unrecognized ("silent") obstruction of fetal and maternal lower body oxygenation-- mother feels well in her position and does not change position to protect fetus

Figure 4
Counterproductive cardiovascular “compensation”: When a mother adopts a body position in which her uterus blocks her venous system, the amount of blood returning to the heart decreases, and this reduced venous return promptly results in a decreased cardiac output (the amount of blood that the mother's heart pumps out per minute). The cardiovascular systems of some women compensate for this reduction in cardiac output by keeping the mother's blood pressure normal-- which results in the mother continuing to feel well in her new unfavorable body position, even though the fetus may be suffering from a lack of oxygen. If prolonged, this lack of oxygen may result in permanent injury to the fetus, placenta or myometrium.

Therefore this "well-meaning" blood pressure "compensation" (which is “meant” to keep the mother conscious and functional) may be harmful to the developing fetus, placenta or maternal tissues. In this Figure we see that although the mother feels well, her fetus, placenta and uterus may not be getting all the oxygen they need for optimal development and function, and this lack of oxygen may contribute to preeclampsia, fetal growth restriction, preterm birth, dysfunctional labor, cesarean delivery and postpartum hemorrhage.

Another important aspect of this unproven theory is that the possible injury to the fetus, placenta or myometrium may be caused more by the elevation of uterine venous pressure than by the reduction in cardiac output per se. But the positional reduction of cardiac output can now be detected by non-invasive technology and can therefore serve as a "marker" for an unfavorable maternal body position-- even though the reduced cardiac output may not be-- by itself-- the most important cause of injury!
Please be aware that this theory-- while plausible-- is completely unproven-- which explains the need for further research.

Abbreviations: IVC inferior vena cava, L patient’s left side, O2 oxygen, R patient’s right side

Figure 5"Cardiac output-guided maternal positioning" is the term I invented to describe the idea that a mother who is feeling comfortable in her current body position could receive a warning signal from a device telling her to change her body position because her current position might be endangering her fetus. The device would make this recommendation based on a positional reduction in the mother's cardiac output.

Figure 5
"Cardiac output-guided maternal positioning": A positional decrease in maternal cardiac output serves as a real-time warning signal to the mother to change her body position to protect her fetus from possible injury-- even though the pregnant woman may feel comfortable in her current body position.

This Figure schematically lays out the process by which a pregnant woman receives a warning from a wearable device about a "silent" unrecognized threat to her fetus and changes her body position to protect the fetus, even though she feels well in her current body position.

The positional decreases in maternal cardiac output caused by OUVR (which are known to occur) might be detectable in the future using wearable and completely non-invasive sensors in the form of “rings,” “bracelets” or “earrings.” These wearable devices would have to be developed if the basic theory of this website is shown to have validity by further research. My present model uses a positional decrease in maternal cardiac output to trigger the warning signal to the mother, but positional changes in maternal heart rate variability (HRV) might be able to provide the warning as well-- but this use of HRV for this purpose is completely speculative at this time.

The irony is that obstetricians and anesthesiologists already perform this type of intervention during labor, due to decreases in a mother's blood pressure or the baby's heart rate. My new idea is to do this systematically during the second half of pregnancy, based upon an objective measurement of cardiac output, rather than blood pressure or heart rate.

This Figure is speculative and much further research is needed to confirm or disprove the concepts shown.

Abbreviations: CO cardiac output, IVC inferior vena cava

Three articles by Dr. Greggory R. DeVore

ChatGPT Pro has made me aware of a new publication suggesting that small placentas may be a factor in stillbirth. Here is the verbatim language from ChatGPT (I have put key language in bold font):

“Small placentas were strongly overrepresented in stillbirth

Cheng M, Marsden T, Warrilow K, et al. “Small placental size is common in stillbirths, including unexplained late-gestation stillbirths.” Journal of Perinatal Medicine, October 27, 2026. DOI: 10.1515/jpm-2026-0349 PubMed

  • New finding: Among 390 freshly trimmed stillbirth placentas, small placentas were approximately seven times more common than in livebirth reference data. Term stillbirths were more likely than preterm stillbirths to have a small placenta, and small placental size was also associated with the “unexplained” subgroup.
  • Evidence strength: Moderate for a structural association, weak for mechanism. Strengths include standardized fresh placental measurements and formal stillbirth classification. Limitations include retrospective, post-event assessment; comparison with livebirth reference data rather than contemporaneous matched controls; and inability to determine whether small size caused vulnerability, reflected pre-existing disease, or resulted from impaired growth.
  • Relevance to OUVR: A small placenta plausibly has less exchange and hemodynamic reserve, making it more susceptible to transient reductions in maternal perfusion or increased IVSP. That is an inference only. The study measured neither oxygenation nor maternal or placental hemodynamics, so it cannot connect unexplained stillbirth to maternal position or OUVR.”

Direct measurement of femoral vein diameter to detect positional obstruction of uterine venous return (OUVR)

This alert from ChatGPT Pro then made me think (again) about how to directly but non-invasively detect increased intra-abdominal venous pressure during pregnancy. Perhaps a wearable array of tiny ultrasound transducers on a pregnant woman’s thigh could monitor femoral vein diameter and give the woman a warning when that diameter had markedly increased. This direct examination of the lower body venous system would be another way of detecting obstruction of uterine venous return. This approach should be easy for patients and clinicians to understand and accept, since other problems with the venous system during pregnancy, such as varicose leg veins and hemorrhoids, are well known clinically.

Dr. Archer has agreed to consult on an unpaid basis with Osypka Medical, Inc. regarding medical education and device development.

El valor de medir el gasto cardíaco durante el embarazo

Spanish-language presentation by Thomas L. Archer, MD, MBA (54 slides), exploring cardiac output measurement during pregnancy, electrical cardiometry, and maternal positioning. I will be giving this talk on November 4, 2026 in an online seminar sponsored by Osypka Medical, Inc. for a Latin American audience.

View the presentation (PDF)

Download the PowerPoint presentation (.pptx)

Blog

Thomas L. Archer wearing a red shirt, with a mountain landscape behind him

Thomas L. Archer, MD, MBA

Osypka Medical, Inc. has invited me to consult for them on an unpaid basis about medical education and device development. I worked with their technology for many years at UCSD and am looking forward to possibly helping make it even better and also spreading the word in Latin America about what may be important ideas for improving fetal and maternal health. Dr. Greggory DeVore, whose work I admire, also sent me an encouraging note. So, all in all, I am feeling optimistic that the ideas presented in this website may finally be getting some "traction." I encourage everyone to read Dr. DeVore's important work.

Green Colombian mountain landscape beneath a cloudy sky

Osypka Medical, Inc.-- who makes the Electrical Cardiometry equipment I used for my research at UCSD-- has asked me to give an online seminar to a group of healthcare professionals living and working in Latin America, and I will be doing that on November 4, 2026. That request started me thinking about whether there might be something special that I should say to this geographical group, and I realized that perhaps there was, indeed, a Latin American “angle” to the idea of protecting fetal oxygenation via favorable maternal positioning.

My working theory (which is completely unproven) is that preventing obstruction of uterine venous return might enhance fetal oxygenation and normal development in some or even many pregnant women, regardless of where they live. But the Latin American “angle” might be as follows: many Latin American women live at relatively high altitudes, and it is already known that living at altitude decreases birthweight, particularly for women who are not genetically adapted. Hence, it seems that it is known that an ambient low oxygen tension does, in fact, constitute a special stress on a fetus—a “first hit,” to use the terminology of this website and my book. Similarly, for many reasons, many Latin American women are anemic, and this lack of oxygen carrying capacity may constitute another type of stress or “first hit” to adequate fetal oxygenation. Hence, both living at high altitude and maternal anemia may constitute dangerous “first hits” whose effects may be exacerbated by the “second hit” of obstruction of uterine venous return.

To carry that logic even further-- and to talk about all women everywhere-- there are other “first hit” stresses in some pregnancies—such as obesity, diabetes, chronic hypertension and advanced maternal age—which constitute additional threats, or “first hits” to fetal, placental and myometrial oxygenation. This consideration—which applies to all women—rounds out this brief meditation about first and second “hits,” whether in Latin America or elsewhere.

About the author

Thomas L. Archer, MD, MBA is a Board-certified anesthesiologist. After about twenty years in the private practice of general anesthesiology, he enjoyed thirteen years of academic anesthesiology practice at Stanford, The University of Texas Health Science Center in San Antonio and, finally, at the University of California San Diego (UCSD). It was at UCSD-- as a Clinical Professor of Anesthesiology and Director of Obstetric Anesthesia-- where he developed the ideas presented in his two books and this website. Dr. Archer will also be establishing a presence on X, under the "handle" of @FetalOxygenMD. Dr. Archer retired from clinical practice at UCSD in 2015, but has remained active academically since then-- authoring medical articles, giving presentations at conferences, writing two books and generally attempting to stir up interest in what he believes might be important ideas for improving lifelong pregnancy outcomes for mothers and their children.

Books

Threats to Fetal, Placental and Myometrial Oxygenation: A Unified Hemodynamic Approach

Thomas L. Archer · 2024

A detailed presentation of the proposed hemodynamic mechanisms discussed on this site.

View and purchase on Springer Nature

Obstetric Anesthesia: A Case-Based and Visual Approach

Edited by Thomas L. Archer · 2020

An illustrated clinical case book on obstetric anesthesia, maternal care and fetal oxygenation.

View and purchase on Springer Nature
Research & Devices

Device requirements

This Pregnancy Hemodynamics website focuses on the theory that positional obstruction of uterine venous return (OUVR) is a preventable cause of hypoxic injury to the fetus, placenta or mother. Another key theory presented by this website (and my book) is that positional decreases in maternal cardiac output can be used as a “marker” to detect and correct this positional OUVR when it occurs. Therefore, to research these two theories, any device used to measure cardiac output should have the following characteristics:

1. The device gives reliable cardiac output information in all maternal positions, including the a) supine position (flat on the back, looking upward), b) Fowler’s position (like the supine position but with the back and head raised, and with some flexion at the knees, c) the full range of left and right lateral positions, with varying degrees of tilt, d) the sitting position and e) the standing position.

This requirement that the device gives reliable cardiac output trending information in all maternal positions is absolutely indispensable for this research to have any validity, and—- it would seem-- that the best technologies to fulfill this “all-positions” requirement would measure the stroke volume from "central" parts of the maternal circulation (such as the thorax or head and neck) rather than from "peripheral" locations (such as a fingertip).

This preference for measuring stroke volume from a “central” location would seem to put impedance cardiography or the USCOM device amongst the best current candidates for this research. As is noted below, however, optical plethysmography on the pulse in an earlobe might also be an excellent candidate technology, since the head is also a “central” location for acquiring stroke volume information. Perhaps someone will develop a cardiac output-trending "earring" for ambulatory cardiac output-guided maternal positioning during pregnancy.

2. As a corollary to requirement #1 above, the device must reliably show the direction of change of cardiac output from one maternal position to another-- although the device does not have to give correct absolute values for cardiac output, and (in my opinion) investigators should not spend their valuable time trying to obtain correct absolute values for cardiac output, since accurate trending should be sufficient.

This use of a device to reliably determine the direction of change of a measurement without necessarily giving correct absolute values, is called “trending.” Therefore, we can summarize this device requirement by saying that the device must trend cardiac output reliably from one maternal body position to another.

3. The device should trend cardiac output continuously.

4. The device should trend cardiac output in a “hands-free” manner—in other words, the device needs to be able to acquire data in the absence of an operator

5. The device should be easy to use, without requiring advanced training.

6. The device should be completely non-invasive and discomfort-free.

7. Ideally—if the theories presented in this website turn out to have value and it becomes apparent that a cardiac output trending device for ambulatory patient use is required, the device should be wearable and cosmetically acceptable to a pregnant woman.

Specific device recommendations:

The devices I recommend for the first stage of research are as follows:

1) The USCOM Doppler ultrasound device, which will be used as the reference standard to validate

2) Electrical cardiometry (EC), as embodied in the ICON impedance cardiography system.

Electrical cardiometry fulfills all of the requirements for a suitable research device set forth above (whereas USCOM does not), but in order to be credible, EC should have “positional validation” by using USCOM as the reference standard.

“Positional validation” of Electrical Cardiometry using the USCOM device as the reference standard

I propose that investigators use the ICON EC device (or similar impedance cardiography systems) for future studies of positional changes in maternal cardiac output—at least until better methods appear in the marketplace-- but before those future studies can be performed it is necessary to “positionally validate” the ICON device. I use the term “positional validation” to mean that investigators must first prove that their method of measuring maternal cardiac output is not artifactually affected by maternal position. In other words, investigators must prove that a maternal position change does not change the value of cardiac output reported by EC when the true value—as determined by the USCOM reference standard-- does not change.

The strongest reason for using the USCOM device as the reference standard for cardiac output measurements in studies involving position change is that it measures stroke volume by recording the velocity-time integral (VTI) of blood emerging from the heart directly within the ascending aorta, rather than by a less direct method. Secondary reasons for using USCOM as the reference standard are that it is easy to use after brief training, and each measurement can be obtained quickly. The big disadvantages of the USCOM device for extensive research are that USCOM is not hands-free or continuous. For this reason, I advise the use of EC for extensive research-- assuming that EC can be "positionally validated."

After “positional validation,” EC can be used as the sole technique for further positional studies

If EC is shown to accurately identify the direction and approximate magnitude of change of maternal cardiac output with maternal position change, it can be used for all the subsequent studies suggested below. Electrical cardiometry is an excellent tool for researching trends in cardiac output, since it fulfills all of the first six requirements listed above for the ideal research device.

Proposed sequence of studies

A paper of mine from 2025 presents these proposed types of studies in detail, but here is a short summary:

Study #1:
Does EC have “positional reliability” compared to USCOM as the reference standard?

Study #2:
Perform exploratory and observational pilot studies of maternal cardiac output during labor, observing changes due to maternal position, epidural analgesia, uterine contractions with autotransfusion and administration of medications such as vasopressors, oxytocin, magnesium sulfate or tocolytics.

Study #3:
Therapeutic trials of cardiac output-guided maternal positioning during labor to reduce outcomes such as “fetal distress,” cesarean delivery, dysfunctional labor requiring uterotonic administration and postpartum hemorrhage or infection.

Study #4:
Observational association studies on hospitalized patient not in labor. Do patients hospitalized for preterm labor, fetal growth restriction or preeclampsia have more positional variability of cardiac output than healthy controls?

Study #5:
Therapeutic trials of cardiac output-guided maternal positioning in hospitalized patients not in labor. Can preterm labor, fetal growth restriction or preeclampsia be successfully treated using cardiac output-guided maternal position therapy?

Study #6:
Home-based cardiac output-guided maternal “position therapy” to prevent or treat preterm labor, fetal growth restriction or preeclampsia.

Study #7:
Twenty-four hour per day ambulatory cardiac output-guided maternal positioning with wearable devices. Making “maternal position optimization for optimal fetal oxygenation” part of routine prenatal care.

Device development opportunity

An exciting idea for medical device development would be to use the optical plethysmography tracing from a pulse oximeter probe placed on a pregnant woman's earlobe (as an "earring") to capture a value correlating with the stroke volume within that individual. In this way, an easily acceptable "earring" device for trending maternal cardiac output within one individual (without the need for correct absolute values) might allow cardiac output-guided maternal positioning using pulse contour technology. The advantage of using the earlobe as a monitoring site, instead of a finger, would be that perfusion of the earlobe might be less position-dependent than the perfusion of a fingertip, which could be affected by positional compression of the brachial artery.

Contact and comment

I welcome questions, comments and research discussion about the ideas presented on this website.

Please email me at fetaloxygenmd@hotmail.com.

Thomas L. Archer, MD, MBA

Please do not include personal medical information. I cannot provide individual medical advice through this website or by email. This email address is not monitored for emergencies.

Cardiac output-guided maternal positioning

The idea is also to immediately warn a pregnant woman when her current body position appears to be capable of restricting oxygen delivery to her developing baby. Working with known medical concepts and available technology, bioengineers would develop wearable devices which would provide this real-time warning to pregnant women, and the devices would additionally reassure the mother when she had adopted a body position which appears to be better for the baby's growth and development.

View Figure 5: Cardiac output-guided maternal positioning

Prenatal positional oxygenation management

All that remains is to determine whether such “guided maternal positioning” really makes a difference in fetal and maternal health and specific pregnancy outcomes. If it does, then “positional oxygenation management” during the second half of pregnancy (when the uterus is large enough to obstruct its own blood flow) might become a routine part of prenatal care.

View the proposed research

Key concepts

This website and its "novel" or "crazy" ideas may be very confusing, but perhaps this list of some key concepts will be helpful.

  1. The theory presented by this website is—on the one hand—very simple: that obstruction of the blood supply to the uterus during pregnancy can cause problems. On the other hand, this issue has been hard to study since such obstruction has been hard to detect both easily and reliably. The question as to whether the chronic obstruction of the blood supply of the uterus during pregnancy could cause long term problems for the fetus or the mother has not been studied at all.

  2. I have created this website because my clinical research work with modern non-invasive hemodynamic technology has convinced me that we are now able to detect obstruction to the blood supply of the uterus much more easily and continuously than in the past, and that we should use this technology to study the hitherto unknown effects of such obstruction on the fetus, placenta and myometrium —particularly the unknown effects of chronic blood flow obstruction.

  3. It is known-- for sure-- that the pregnant uterus can—and does—obstruct its own blood supply in certain maternal body positions in many women during the second half of pregnancy. In fact, this concept has been demonstrated many, many times and it is a fundamental concept in both obstetrics and obstetric anesthesia, as well as in the general care of the pregnant patient. The most common point of obstruction is the inferior vena cava, which is the major vein carrying blood back to the heart from the lower part of the body—including the uterus. The fact that this phenomenon does occur-- and can be dangerous when it occurs-- was one solid point of origin for developing the speculative theories presented in this website and in my book.

  4. This obstruction of uterine venous return (OUVR) varies greatly from woman to woman, and this variability makes the study of its effects even more difficult.

  5. Obstruction of uterine venous return at the inferior vena cava can cause two effects on the maternal cardiovascular system: first, a decrease in the cardiac output (the amount of blood pumped out by the heart every minute), and second, an increase in uterine venous pressure. The first effect—the decrease in maternal cardiac output—can be detected with current non-invasive technology, but the second effect—the increase in uterine venous pressure—cannot be detected using current technology.

  6. Because of point 5), decreases in maternal cardiac output can be used as a “warning indicator” or “marker” of OUVR, even though the decrease in cardiac output, per se, may not be the main cause of any of the hypothetical injuries discussed in this website. Another way of saying this is that the increase in uterine venous pressure may be far more harmful than the decrease in cardiac output in causing any injury, but the relative importance of these two factors is unknown, as is the question as to whether either factor really causes any fetal, placental or myometrial injury at all.

  7. Obstruction of uterine venous return (OUVR) is usually greater in degree in the supine position (flat on the back) than in lateral positions (on the side), and OUVR is usually relieved when the patient turns onto one side or another. Additionally, the left-side-down position is usually the better of the two lateral positions for relieving OUVR, but not always. Sometimes having the right side down is better.

  8. It is also known that when the veins of an organ (“the venous drainage”) are blocked, it can cause severe problems for the organ involved. Here is an example of what happens when you put a tourniquet on my hand—the veins engorge, and if the tourniquet were left on, my hand would swell and sustain injury-- perhaps permanent injury.

Medical word definitions

Disclaimer: These are informal and plain language definitions which I have created from my own knowledge. The definitions may be wrong or misleadingly simplistic. Like this entire website, these definitions are meant to be informal and conversational and are not meant to be authoritative. They are meant to stimulate thought and discussion.

Anti-angiogenic factors — chemicals released into the mother’s bloodstream by the placenta when it is not getting enough oxygen. These chemicals are thought to cause preeclampsia, a dangerous complication of pregnancy, involving high blood pressure, body swelling and other serious organ damage in the mother—as well as possible fetal growth restriction (below normal growth of fetus).

Aorta — the main artery of the body, starting at the heart and carrying oxygen-containing blood to the entire body

Aortocaval compression (ACC) — when the pregnant (“gravid”) uterus physically compresses and blocks blood flow through both the aorta (the main artery of the body, which carries oxygenated blood away from the heart to the organs of the body) and the inferior vena cava (the biggest vein in the abdomen, which carries blood back to the heart so it can pick up more oxygen in the lungs).

Arteries — the blood vessels taking well-oxygenated blood away from the heart and delivering it to the organs of the body

Autotransfusion — During labor, the uterus contracts to push the baby down the birth canal, and these contractions squeeze some of the mother’s blood which is inside the uterine muscle back into the mother’s active circulation. This autotransfusion causes a measurable increase in the mother’s cardiac output for a brief period of time. Autotransfusion can be detected and followed by using commercially available and non-invasive technology such as Electrical Cardiometry.

Blood pressure (BP) — the pressure (force per unit area) that the blood has while it is within an artery or vein. Usually, the term applies to the pressure of the blood within arteries, but the blood pressure within veins (the “venous pressure”) is also important within the body. Venous pressure that is too high can prevent organs from receiving blood flow and oxygen and can also cause organ swelling (called “edema”).

Cardiac output (CO) — The volume of blood the heart pumps out to the body each minute. The CO is measured in liters per minute and abbreviated as “L/min”

Cardiac output-guided maternal positioning (COGMP) — The use of positional decreases in the mother’s cardiac output to diagnose a mother’s body position which may be bad for the baby growing inside the mother (the “fetus”). The term is new and is not in wide use. This idea is one of the main new ideas of this website.

Cardiovascular compensation — The idea that the mother’s heart and blood vessel system (cardiovascular system) can keep the mother’s blood pressure in the normal range, even though the mother’s cardiac output has been decreased by obstruction of the main vein of the lower body, the inferior vena cava.

Cardiovascular system — The entire system of the heart, blood vessels and the nerves that control those organs. Regulation of the cardiovascular system is extremely complicated!

Cesarean delivery (CD) — The more modern term for “cesarean section,” or the delivery of the baby from the mother by means of surgery through the lower abdomen.

Chorionic villi / chorionic villus — The parts of the placenta (fetal tissue) that contain some of the fetus’ blood vessels, which pick up oxygen (by diffusion) from the mother. The bloodstreams of the baby and the mother normally do not mix to any significant extent, and all of the transfer of oxygen, carbon dioxide, food molecules and waste products to and from the fetus occurs by various types of transfer across tissue. The commonest form of transfer from one bloodstream to another is called “diffusion.”

Chronic — adjective describing something that happens over a long period of time. Used in contrast to “acute” which means something that occurs all of a sudden.

Doppler ultrasound — the medical use of sound waves to gather medical images and other types of medical information, such as the speed of blood flow in parts of the body.

Dysfunctional labor — When the contractions of the uterus during labor do not work well to push the baby down the birth canal. One common type of dysfunctional labor is when the uterine muscle (myometrium) loses strength during labor, and this type of dysfunctional labor can be caused by a lack of oxygen in the myometrium.

Electrical cardiometry (EC) — A type of electrical measurement of the cardiovascular system sold by Osypka Medical, Inc. Electrical cardiometry is one type or “brand” of what is called “impedance cardiography.” Other types of impedance cardiography are available commercially, but the type I used in my research was electrical cardiometry.

Electrical velocimetry — A term closely related to “electrical cardiometry” which means “measuring the speed of blood flow.”

Endometritis — Infection of the inside of the uterus occurring after delivery of the baby

Epidural analgesia (“an epidural”) — A type of pain relief administered to a pregnant woman to relieve labor pain. It is given into a mother’s back through a tiny, flexible tube.

“Fetal distress” — An older term that has largely been replaced by the term “non-reassuring fetal heart tones.” The condition is usually diagnosed by a slowing of the fetus’ heart rate, and this slowing is sometimes caused by a lack of oxygen in the fetus.

Fetal growth restriction (FGR) — An abnormally low amount of fetal size or growth. The term used to be called “fetal growth retardation,” but was changed because the word “retardation” suggested the phrase “mental retardation.”

Fetoplacental perfusion — the blood flow to the placenta coming from the fetal heart. This blood flow is completely separate from the “uteroplacental perfusion” which is blood flow coming from the mother’s heart. Exchange of gases, food molecules and waste products occurs from one bloodstream to another across the tissue of the chorionic villi (the “placental barrier”) by diffusion and other mechanisms.

Fetus / fetal — The term for the baby while it is developing inside the mother’s uterus, before delivery. Once the fetus comes out of the mother, the fetus is called a “baby.”

Gravid uterus — “Gravid” means “pregnant” or “carrying a fetus.” So, “gravid uterus” means a woman’s uterus with a developing fetus inside. When the fetus becomes large during the second half of pregnancy, the gravid uterus can block blood flow back to the mother’s heart through the major vein of the lower body (the “inferior vena cava”)

Hemodynamics / hemodynamic — means the study or process of how the heart pumps oxygen-carrying blood to the organs of the body and back again to the heart, for re-oxygenation in the lungs. Another term for the flow of blood within the body.

Hemorrhage — Uncontrolled or unwanted loss of blood from blood vessels

Hypotensive / hypotension — means “having a blood pressure which may be too low for health”

Hypoxemia — low and unhealthy amounts of oxygen in blood.

Hypoxia / hypoxic — refers to an unhealthy low level of oxygen in a tissue organ or individual

Inferior vena cava (IVC) — the main large vein carrying venous blood from the lower body back to the heart. The pregnant (“gravid”) uterus can block the IVC within the abdomen during the second half of pregnancy.

Intervillous blood flow — the flow of maternal blood around the chorionic villi within the placenta. The blood enters the “intervillous space” through the “spiral arteries” and leaves the space through the uterine venous system, which can be blocked by the pregnant uterus.

Intervillous perfusion — another name for “intervillous blood flow,” the flow of maternal blood around the chorionic villi within the placenta. “Perfusion” means the flow into and then out of an organ.

Intervillous space (IVS) — The space or volume containing the maternal blood flows around and surrounds the chorionic villi, which are the “fingers” of fetal placental tissue containing the fetal blood vessels. The flow of blood (“perfusion”) through the IVS starts with blood coming out of the maternal “spiral arteries” and ends when that blood enters the maternal “spiral veins” which are the start of the uterine venous return system which carries blood back to the mother’s heart.

Intervillous space pressure (IVSP) — The pressure of the blood within the intervillous space. When the intervillous space pressure increases due to obstruction of the uterine venous system, it can compress the chorionic villi and reduce fetoplacental perfusion—which could be dangerous for the fetus.

Ischemia / ischemic — describes the situation when an organ is not getting all the blood flow (“perfusion”) it needs to stay healthy.

IVC obstruction — obstruction (blockage) of the inferior vena cava

Lateral position — when the mother lies on one side or the other. Left lateral means the left side of the body is down, whereas right lateral means that the right side of the body is down.

Maternal — refers to the pregnant woman who is going to give birth to a baby

Maternal–fetal medicine (MFM) — that sub-specialization within the specialty of Obstetrics and Gynecology which refers to the advanced care of the pregnant woman and fetus, considering both mother and fetus as “patients” and as a closely-coupled pair of individuals. MFM specialists are trained obstetrician-gynecologists (OBGYNs) who then receive several more years of advanced training after becoming OBGYNs in order to become MFM specialists—who are often called “perinatologists.”

Myometrial ischemia — lack of adequate blood flow and oxygen delivery to the smooth muscle of the uterus which contracts during labor. Myometrial ischemia can be a cause of poor uterine contractions during labor.

Myometrium / myometrial — Refers to the smooth muscle of the uterus which normally contracts strongly during normal labor.

Non-invasive — refers to medical monitoring or measuring techniques or devices which do not require any insertion of anything into the body across the skin, such as small plastic tubes or “cannulae.” Non-invasive techniques are usually pain-free, easier to perform and much less risky than “invasive” techniques such as sticking plastic tubes into blood vessels through the skin.

Normoxic — means that the amount of oxygen in something (e.g. blood or tissue) is at a normal and healthy level

Obstetric anesthesia — a subspecialty of Anesthesiology and Critical Care, which has to do with the care of pregnant women and their fetuses.

Obstetrician — a doctor who takes care of pregnant women

Obstetrics / obstetric — the medical care of pregnant women

Obstruction of uterine venous return (OUVR) — a key phrase for this website, meaning any blockage to the de-oxygenated venous blood coming out of the uterus that is “trying” to get back to the heart. A key point of this website is that OUVR can increase pressure within the placenta which can reduce oxygen delivery to the developing fetus.

Oxygen (O2) — the gas in our air that is needed for life by all animals. Air contains 21% oxygen, with almost all the rest being nitrogen (N2).

Oxygen partial pressure (pO2) — the amount or pressure of oxygen within a gas or a liquid such as blood.

Oxygenation — the process of  putting oxygen into a tissue to enable it to live. Normally, tissues are “oxygenated” when they receive the flow of oxygen-carrying blood.

Oxytocin — a medication used in obstetrics to increase the frequency or strength of uterine contractions, usually during labor. Oxytocin also occurs naturally in the body, and is released when the baby sucks on the mother’s nipple during breastfeeding.

Perfusion — the successful flow of blood into and out of an organ. Perfusion normally causes oxygenation of tissue.

Perfusion pressure — the mathematical difference between the arterial pressure and the venous pressure for an organ. An increase in venous pressure with a constant arterial pressure decreases the perfusion pressure.

Perinatology — the field of medicine concerned with the advanced medical care of pregnant women and their fetuses. Perinatologists receive further years of advanced training after becoming obstetrician-gynecologists (OBGYNs). The field of perinatology is also called “maternal fetal medicine” or MFM.

Placenta / placental — the placenta is almost entirely fetal tissue, with just a tiny amount of maternal tissue (the “decidua”) breaking away from the uterus at the time of delivery. The placenta is the organ that allows exchange of everything (oxygen, carbon dioxide, food molecules, waste molecules, signaling molecules, etc.) between the pregnant woman and her fetus during pregnancy. The separate circulations of the fetus and the mother do not mix during normal pregnancy (with rare exceptions), and all of the exchange between fetus and mother occurs across the part of the chorionic villi which is called the placental membrane.

Positional fetal oxygenation management — the term (which I believe I invented) to describe the use of maternal positioning to enhance the delivery of oxygen to the fetus.

Postpartum — after delivery

Postpartum hemorrhage — excessive maternal bleeding after delivery of the baby

Postpartum uterine atony — inadequate contraction of the uterus after delivery. This website presents the theory that poor myometrial oxygenation during labor can be a cause of postpartum uterine atony.

Preeclampsia — A dangerous syndrome occurring after 20 weeks of pregnancy, involving maternal high blood pressure, body swelling and maternal organ injury and dysfunction, such as having protein in the urine and decreased kidney function. Preeclampsia has been the subject of intensive study for more than a century, and much progress has been made in its diagnosis and treatment, but it is still poorly understood and a major pregnancy problem whose incidence is not decreasing.

Prenatal care — the process of care of the pregnant woman before birth

Preterm birth — birth before 37 completed weeks of pregnancy

Preterm labor — onset of labor before 37 completed weeks of pregnancy

Spiral arteries — the small maternal arteries that eject maternal blood into the intervillous spaces of the placenta, so that the blood can come in contact with the chorionic villi and give oxygen to the fetus. A major theory of preeclampsia is that it has to do with “inadequate remodeling” of the spiral arteries, resulting in an inadequate release of maternal blood into the intervillous spaces.

Spiral artery remodeling — the process by which the spiral arteries (see above) are converted from high resistance arteries to low resistance arteries, which increases the flow rate of maternal blood into the intervillous spaces to satisfy the fetus’ growing need for oxygen.

Supine hypotensive syndrome of pregnancy — the maternal syndrome of pallor, dizziness, nausea and vomiting, rapid heart rate, low blood pressure and possible loss of consciousness that sometimes happens to pregnant women late in pregnancy who lie flat on their backs (supine). The syndrome is caused by the uterus blocking a lot of blood from getting back to the heart and this causes a serious decrease in blood pressure, which then causes the syndrome.

Systemic vascular resistance — the total resistance of (mostly) the arterial system to the blood pumped out by the heart. You can think of it like putting your thumb over the mouth of a garden hose: the partial blockage of flow increases the pressure of the stream of water, but decreases the amount of water that actually comes out of the hose.

Transthoracic echocardiography — The use of high-frequency (inaudible) sound waves to form moving images of the heart. Over the last 50 years, it has become a key medical procedure for “looking at” the beating heart in real time.

Two-hit hypothesis — the idea that it takes two problems to cause a major problem. In other words, that two different problems cause much more damage together than either problem alone. In this website I present the hypothesis that obstruction of uterine venous return (OUVR) can act as a “second hit” and make other threats to fetal oxygenation (such as poor spiral artery remodeling) much more dangerous. This example may be important because OUVR can be prevented-- even though the “first hit” may not be preventable at all.

USCOM (Ultrasound cardiac output monitor) — a commercially available device which uses sound waves to “look at” the blood flow within the ascending aorta to see how fast the blood is flowing out of the heart and how long the flow lasts. The device “looks at” the blood flow in the ascending aorta through an “ultrasound window” that lets sound waves pass through it which is located at the top of the breastbone at the base of the neck. The “ultrasound window” is called the “sternal notch” and you can feel it on yourself with your finger.

Ultrasound — high frequency sound waves used for “looking” inside the body and creating images of structures like the heart, liver or blood vessels.

Umbilical artery — the fetal artery which carries less oxygenated blood from the fetus to the placenta, where the blood picks up more oxygen to meet the needs of the fetus.

Umbilical vein — the fetal vein which brings more oxygenated blood back to the fetus from the placenta

Uterine atony — poor tone (or degree of constant contraction) of the uterus after delivery. Uterine atony often causes postpartum hemorrhage, and this website presents the theory that postpartum uterine atony could be caused—at least in part—by poor oxygenation of the myometrium during labor, due to obstruction of uterine venous return (OUVR) during labor.

Uteroplacental perfusion — the blood flow to the placenta coming from the mother’s heart. This blood flow is completely separate from the “fetoplacental perfusion” which is blood flow coming from the fetus’ heart. Exchange of gases, food molecules and waste products occurs from one bloodstream to another across the tissue of the chorionic villi (the “placental barrier”) by diffusion and other mechanisms.

Veins — the thin-walled blood vessels that normally carry de-oxygenated blood back to the heart, so that the blood can be pumped to the lungs by the right ventricle to pick up more oxygen.

Venous pressure — normally, venous pressure is very low compared to arterial pressure, and the difference between the two pressures across an organ is called that organ’s “perfusion pressure.” When venous pressure increases, it causes two potential problems: 1) decreased organ perfusion, and 2) swelling of the organ, with edema formation and resulting organ dysfunction.

Venous return — a global term used to describe the total amount of venous blood that comes back to the heart, from both inferior and the superior venae cavae. A very important insight is that—in a steady state when everything is stable—the cardiac output is the same as the venous return. After all, the heart can only pump out all the blood that it receives from the veins! A corollary of this fact is that when the uterus blocks the inferior vena cava within the abdomen it blocks the venous return and the maternal cardiac output decreases. These positional decreases of maternal cardiac output can be used to detect and correct the obstruction of uterine venous return that occurs when the inferior vena cava is obstructed.

References

Read the original article and references